they did a conf call earlier in the year and it sounded really positive and brought in volume... they've been hiring and brought in a CRO all signs point to their phaseIIb trial going forward BIIIG question is whether they do a stock offering or partner with big pharma i think the drifting is a combo of uncertainty and shorts if it does a placement i wouldn't think it would be lower than .60.......'if' they partner with a big pharma.. i think it's an overnight doubler ALL IMO of course g/l